OpenAlex
PricingAboutJobs
Log inGet started
Work

Abstract #1795: In Vitro and in vivo activity of ARRY-380: A potent, small molecule inhibitor of ErbB2.

HTML

Year: 2009
Type: conference-abstract
Source: Cancer Research
Authors: Tracy Pheneger, Karyn Bouhana, Deborah Anderson, Jennifer Garrus, Kateri A. Ahrendt, Shelley J Allen, Ira von Carlowitz, Julie Greschuk, Stefan Groß, Keith L. Hoffman, Christine Lemieux, Joe Lyssikatos, Michele Callejo, Gene Tarlton, Eli Wallace, Shannon L. Winski, Rich Woessner, Qian Zhao, Fred P. Marmsater, Patrice Lee
Institution: Array BioPharma (United States)
Language: English

Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: HER2, small-molecule kinase inhibitors, ErbB receptors, breast cancer, ovarian cancer, gastric cancer, tumor xenografts, Akt phosphorylation, apoptosis, ADME properties, oral bioavailability, drug metabolism, trastuzumab, lapatinib, targeted cancer therapy, tumor growth inhibition, BT474 cells, NCI-N87 cells, dose-limiting toxicity
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3163885867
Cites:
Cited by: 36
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security